Favipiravir (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Favipiravir" in Czech language version.

refsWebsite

Global rank Czech rank

8nih.gov

4^th place

8^th place

6doi.org

2^nd place

4^th place

2worldcat.org

5^th place

3^rd place

1clinicaltrials.gov

5,225^th place

2,661^st place

1reuters.com

49^th place

92^nd place

1nytimes.com

7^th place

43^rd place

1plos.org

2,112^th place

284^th place

1sciencemag.org

857^th place

315^th place

1web.archive.org

1^st place

1nhk.or.jp

145^th place

9,820^th place

1idnes.cz

442^nd place

2^nd place

clinicaltrials.gov

Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316, Clinical Trials.gov, March 2015

doi.org

dx.doi.org

FURUTA, Yousuke; KOMENO, Takashi; NAKAMURA, Takaaki. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. S. 449–463. Proceedings of the Japan Academy, Series B [online]. 2017 [cit. 2020-11-18]. Roč. 93, čís. 7, s. 449–463. Dostupné online. DOI 10.2183/pjab.93.027. PMID 28769016. (anglicky)
JIN, Zhinan; SMITH, Lucas K.; RAJWANSHI, Vivek K.; KIM, Baek; DEVAL, Jerome. The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase. S. e68347. PLoS ONE [online]. 2013-07-10 [cit. 2020-11-18]. Roč. 8, čís. 7, s. e68347. Dostupné online. DOI 10.1371/journal.pone.0068347. (anglicky)
BARANOVICH, Tatiana; WONG, Sook-San; ARMSTRONG, Jianling; MARJUKI, Henju; WEBBY, Richard J.; WEBSTER, Robert G.; GOVORKOVA, Elena A. T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro. S. 3741–3751. Journal of Virology [online]. 2013-04-01 [cit. 2020-11-18]. Roč. 87, čís. 7, s. 3741–3751. Dostupné online. DOI 10.1128/JVI.02346-12. PMID 23325689. (anglicky)
NAESENS, Lieve; GUDDAT, Luke W.; KEOUGH, Dianne T.; VAN KUILENBURG, André B. P.; MEIJER, Judith; VANDE VOORDE, Johan; BALZARINI, Jan. Role of Human Hypoxanthine Guanine Phosphoribosyltransferase in Activation of the Antiviral Agent T-705 (Favipiravir). S. 615–629. Molecular Pharmacology [online]. 2013-10 [cit. 2020-11-18]. Roč. 84, čís. 4, s. 615–629. Dostupné online. DOI 10.1124/mol.113.087247. (anglicky)
SISSOKO, Daouda; LAOUENAN, Cedric; FOLKESSON, Elin. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLOS Medicine. 2016-03-01, roč. 13, čís. 3, s. e1001967. Dostupné online [cit. 2020-03-20]. ISSN 1549-1676. DOI 10.1371/journal.pmed.1001967. PMID 26930627. (anglicky)
DELANG, Leen; ABDELNABI, Rana; NEYTS, Johan. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses. S. 85–94. Antiviral Research [online]. 2018-05 [cit. 2020-11-18]. Roč. 153, s. 85–94. Dostupné online. DOI 10.1016/j.antiviral.2018.03.003. PMID 29524445. (anglicky)

idnes.cz

zdenekslanina.blog.idnes.cz

SLANINA, Zdenek. Česko v 1. dvacítce příjemců antikoronaviru Avigan/Favipiravir - Okamura Tomio pohnul SÚKL. Blog iDNES.cz [online]. 2020-04-07 [cit. 2020-11-18]. Dostupné online.

nhk.or.jp

www3.nhk.or.jp

Justin McCurry, China: Avigan effective in tackling coronavirus, NHK News. www3.nhk.or.jp [online]. [cit. 2020-03-19]. Dostupné v archivu pořízeném z originálu.

nih.gov

ncbi.nlm.nih.gov

FURUTA, Yousuke; KOMENO, Takashi; NAKAMURA, Takaaki. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. S. 449–463. Proceedings of the Japan Academy, Series B [online]. 2017 [cit. 2020-11-18]. Roč. 93, čís. 7, s. 449–463. Dostupné online. DOI 10.2183/pjab.93.027. PMID 28769016. (anglicky)
JIN, Zhinan; SMITH, Lucas K.; RAJWANSHI, Vivek K.; KIM, Baek; DEVAL, Jerome. The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase. S. e68347. PLoS ONE [online]. 2013-07-10 [cit. 2020-11-18]. Roč. 8, čís. 7, s. e68347. Dostupné online. DOI 10.1371/journal.pone.0068347. (anglicky)
Baranovich T et al., T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro, J. Virol. 87(7), 2013, pp 3741–3751
BARANOVICH, Tatiana; WONG, Sook-San; ARMSTRONG, Jianling; MARJUKI, Henju; WEBBY, Richard J.; WEBSTER, Robert G.; GOVORKOVA, Elena A. T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro. S. 3741–3751. Journal of Virology [online]. 2013-04-01 [cit. 2020-11-18]. Roč. 87, čís. 7, s. 3741–3751. Dostupné online. DOI 10.1128/JVI.02346-12. PMID 23325689. (anglicky)
SISSOKO, Daouda; LAOUENAN, Cedric; FOLKESSON, Elin. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLOS Medicine. 2016-03-01, roč. 13, čís. 3, s. e1001967. Dostupné online [cit. 2020-03-20]. ISSN 1549-1676. DOI 10.1371/journal.pmed.1001967. PMID 26930627. (anglicky)
DELANG, Leen; ABDELNABI, Rana; NEYTS, Johan. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses. S. 85–94. Antiviral Research [online]. 2018-05 [cit. 2020-11-18]. Roč. 153, s. 85–94. Dostupné online. DOI 10.1016/j.antiviral.2018.03.003. PMID 29524445. (anglicky)

pubmed.ncbi.nlm.nih.gov

NAESENS, Lieve; GUDDAT, Luke W.; KEOUGH, Dianne T.; VAN KUILENBURG, André B. P.; MEIJER, Judith; VANDE VOORDE, Johan; BALZARINI, Jan. Role of Human Hypoxanthine Guanine Phosphoribosyltransferase in Activation of the Antiviral Agent T-705 (Favipiravir). S. 615–629. Molecular Pharmacology [online]. 2013-10 [cit. 2020-11-18]. Roč. 84, čís. 4, s. 615–629. Dostupné online. DOI 10.1124/mol.113.087247. (anglicky)
DELANG, Leen; ABDELNABI, Rana; NEYTS, Johan. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses. S. 85–94. Antiviral Research [online]. 2018-05 [cit. 2020-11-18]. Roč. 153, s. 85–94. Dostupné online. DOI 10.1016/j.antiviral.2018.03.003. PMID 29524445. (anglicky)

nytimes.com

FINK, Sheri. Ebola Drug Aids Some in a Study in West Africa. The New York Times. 2015-02-04. Dostupné online [cit. 2020-03-20]. ISSN 0362-4331. (anglicky)

plos.org

dx.plos.org

SISSOKO, Daouda; LAOUENAN, Cedric; FOLKESSON, Elin. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLOS Medicine. 2016-03-01, roč. 13, čís. 3, s. e1001967. Dostupné online [cit. 2020-03-20]. ISSN 1549-1676. DOI 10.1371/journal.pmed.1001967. PMID 26930627. (anglicky)

reuters.com

First French Ebola patient leaves hospital. Reuters. 2014-10-04. Dostupné online [cit. 2020-03-20]. (anglicky)

sciencemag.org

COHEN, Jon. Results from encouraging Ebola trial scrutinized. Science | AAAS [online]. 2015-02-26 [cit. 2020-03-20]. Dostupné online. (anglicky)

web.archive.org

Justin McCurry, China: Avigan effective in tackling coronavirus, NHK News. www3.nhk.or.jp [online]. [cit. 2020-03-19]. Dostupné v archivu pořízeném z originálu.

worldcat.org

FINK, Sheri. Ebola Drug Aids Some in a Study in West Africa. The New York Times. 2015-02-04. Dostupné online [cit. 2020-03-20]. ISSN 0362-4331. (anglicky)
SISSOKO, Daouda; LAOUENAN, Cedric; FOLKESSON, Elin. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLOS Medicine. 2016-03-01, roč. 13, čís. 3, s. e1001967. Dostupné online [cit. 2020-03-20]. ISSN 1549-1676. DOI 10.1371/journal.pmed.1001967. PMID 26930627. (anglicky)